ArticleLasers in medical science2025
Nonsurgical lower eyelid rejuvenation using a novel 1064-nm Nd:YAG laser with a 650- microsecond pulse duration.
Article in Lasers in medical science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The lower eyelid region is prone to age-related concerns, including wrinkles and dark circles, resulting from structural changes, such as collagen depletion, fat prolapse, and reduced elasticity. Traditional treatments, such as surgery, fillers, and conventional lasers have limitations including risks, downtime, and variable efficacy. This study evaluated the safety and efficacy of a novel 1064-nm neodymium-doped yttrium aluminum garnet (Nd: YAG) laser with a 650 µs pulse duration for noninvasive lower eyelid rejuvenation targeting wrinkles and dark circles. Sixteen participants underwent five weekly treatment sessions, with evaluations at baseline, during treatment, and 1 month post-treatment. The outcomes included quantitative assessments of wrinkles and pigmentation using a facial skin analyzer and participant satisfaction scores. As a result, no significant side effects occurred apart from transient erythema, and participant satisfaction was high. Statistically significant improvements were observed in wrinkle level (baseline: 4.15 ± 1.09; post-treatment: 3.32 ± 1.13, p < 0.001) and dark circle scores (baseline: 69.63 ± 14.09; post-treatment: 77.00 ± 13.59, p < 0.001). The novel 1064 nm Nd: YAG laser with a 650 µs pulse duration offered a painless, downtime-free alternative to traditional treatments and demonstrated significant efficacy in lower eyelid rejuvenation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.